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Abstract: This study reports the generation of a new human muscle tissue equivalent from skeletal muscle-derived stem cells and human
umbilical vein endothelial cells (HUVECs). Skeletal muscle stem cells were isolated by the preplate technique and differentiated into
neuron-like cells that were positive for neuronal beta-tubulin3 and nestin and negative for the astrocyte marker glial fibrillary acidic
protein (GFAP). Coculture of skeletal muscle stem cells with the HUVECs under optimized fetal bovine serum and media conditions
resulted in formation of a capillary network among the multinucleated myotubes. The neuron-like cells derived from the human skeletal
muscle stem cells were seeded onto vascularized myotubes to obtain the neuromuscular junctions in the coculture. At the end of 24 h
of coculture, the neuron-like cells were found to be in association with the myotubes. This model represents a novel complex in vitro
human skeletal muscle model containing advanced capillary networks and interacting myotubes and neurons, and it can be used for
in vitro drug testing or for skeletal muscle regeneration either through application of cellular therapy or cell-laden tissue-engineered
muscle constructs.
Key words: Human skeletal muscle model, skeletal muscle tissue engineering, human skeletal muscle stem cells, neuron-like cells,
vascularization, coculture

1. Introduction
Traumatic injury, congenital defects, or tumor ablations
cause skeletal muscle defects and as a promising
interdisciplinary specialty skeletal muscle tissue
engineering aims at the reconstruction of this loss. There are
limitations for autologous grafting because of the difficulty
in procuring donor tissue. Transfer of an adjacent muscle
tissue in a pediculated form or a distant one as a free flap
is a method often applied in treatment of muscular defects
and losses. The goal here is sometimes just to cover the
defect, but this approach may also be used to restore the
functionality of a contractile muscle. However, long and
difficult surgical procedures are required and sometimes
donor site morbidity brings surgical procedure limitations.
Since the muscles used for coverage sometimes do not
have neural transmission, secondary surgeries are carried
out to provide neurotization and innervation. Generating
new muscle tissue from autologous precursor cells (stem
cells) attempts to manage this problem via skeletal muscle
tissue engineering (Guettier-Sigrist, 1998).
* Correspondence: halime.kenar@kocaeli.edu.tr
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Skeletal muscle consists of basically three major cell
types: myofibers, neurons, and endothelial cells, which are
actively involved in the muscle contraction phenomenon.
Myofibers are large single cells that are formed by fusion of
many cells during development. Bundling of these muscle
fibers results in muscle formation (Sjøgaard et al., 2014).
Skeletal muscle cells are innervated by motor neurons.
Each neuron can control a small number of myofibers
and fires a contraction. There is a need for neuronal
stimulation during myogenesis (Pette et al., 2002). With
the help of tissue engineering principles, differentiated
skeletal muscle tissue can be restored by utilizing multiple
stem or progenitor cells from different sources.
Due to terminal differentiation of mature muscle
fibers, which are vascularized and multinucleated, selfregeneration is not possible. Satellite cells or myoblasts,
first described by Mauro in 1961, are the cells that give
the muscle tissue the ability to regenerate itself. Muscle
injury causes myoblast activation by external stimuli. They
reenter the mitotic cell cycle and form new myofibers or
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fuse with damaged myofibers (Laumonier and Menetrey,
2016). Some of the cells reenter the G0 state and therefore
are capable of maintaining the regenerative potential of
injured muscle tissue (Dhawan and Rondo, 2005; Sinanan
et al., 2006; Dumont et al., 2015; Snijders et al., 2015).
The most preferred source of cells for skeletal muscle
tissue engineering applications is either a myoblast cell
line (Caridade et al., 2015) or the primary satellite cells
that can easily be obtained by muscle biopsies and be
cultured in vitro (Powell et al., 1999). As pioneers in this
field, several research groups have focused on engineering
skeletal muscle tissue that harbored only the myoblasts
in their structure (Choi et al., 2008; Moon et al., 2008;
Eberli et al., 2009; Hosseini et al., 2012). The major goal
of these studies was to obtain the contracting myotubes in
an anisotropic arrangement to mimic the native skeletal
muscle physiology. These were closely followed by other
reports that introduced methods for vascularization of
engineered constructs (De Coppi et al., 2005; Levenberg et
al., 2005; Delo et al., 2008; Klumpp et al., 2012; Shandalov
et al., 2014, 2015). Most approaches were dependent on
the host for generation of a blood vessel system that could
provide enough oxygen and nutrients for survival (De
Coppi et al., 2005; Delo et al., 2008; Klumpp et al., 2012;
Juhas et al., 2014). However, in expanded tissues with a
high oxygen demand like skeletal muscle, vascularization is
a fundamental concern and its prior in vitro establishment
would better help in vivo survival and integration of the
3D implant. Introduction of a capillary network to the
in vitro tissue-engineered muscle was a good strategy
(Levenberg et al., 2005; Shandalov et al., 2014, 2015;
Gholobova et al., 2015), and the in vivo integration of such
a construct was found to be more successful (Levenberg et
al., 2005; Shandalov et al., 2014). As the other invaluable
component of muscle tissue, in vitro establishment of
innervation by the motor neurons would better mimic the
native tissue and provide an opportunity to test the effect
of drugs targeting the neuromuscular junctions (Uzel et
al., 2016). It was shown in a study by Guo et al. (2011) that
an in vitro functional human neuromuscular junction can
be established by coculture of motoneurons derived from
human fetal spinal cord stem cells and myotubes derived
from human skeletal muscle stem cells in a defined serumfree system. Larkin et al. (2007) were successful in obtaining
a functional neuromuscular junction in vitro when they
used a model where 3D skeletal muscle constructs were
cocultured with fetal nerve explants. On the other hand,
both innervated and vascularized human muscle tissue
construct is expected to have a reduced time of functional
integration in the body and eliminate the species-related
variability associated with animal-based systems when
used in drug discovery and toxicology studies.

This study reports a human-based improved in vitro
skeletal muscle model developed by coculture of human
neuron-like cells and myotubes obtained by differentiating
human skeletal muscle-derived stem cells and endothelial
cells from human umbilical vein. Neuron-like cells were
seeded on myotubes that possessed a capillary network
and these were cultured all together for 24 h. Neuron–
myotube interaction and capillary network maintenance
was revealed by confocal microscopy.
2. Materials and methods
2.1. Human skeletal muscle stem cell isolation
Human skeletal muscle stem cells (hSkMSCs) were isolated
with the enzymatic digestion of muscle obtained from
hamstring grafts for anterior cruciate ligament surgery
under the guidelines of the Yeditepe University Hospital
Human Ethics Committee.
The nonpathological human skeletal muscle tissue was
taken into Hank’s Balanced Salt Solution (HBSS; GIBCO,
USA) with 5% Pen/Strep (Biochrom AC, Germany) and
divided into small pieces with the help of a scalpel. An
enzyme cocktail containing 0.1% collagenase I (SigmaAldrich, USA) and 1.38 mg/mL dispase (GIBCO) was
prepared in HBSS and the muscle pieces were incubated
in this solution in a shaking water bath for 2 h at 37 °C.
The final slurry was filtered through a filter with 100 µm
pore size and the filtrate was centrifuged at 1500 rpm
for 5 min. The cells in the pellet were resuspended in
media for washing and centrifuged again under the same
conditions. The pellet was resuspended in DMEM/F12
(1:1) medium supplemented with 20% fetal bovine serum
(FBS), 20 µg/L human recombinant epidermal growth
factor (EGF) (Sigma-Aldrich), and 10 µg/L basic fibroblast
growth factor (bFGF) (Sigma-Aldrich) and precultured
on gelatin-coated flasks, called preplates, for 3 h to reduce
the number of fibroblasts. The unattached cells were
transferred together with the medium to a new uncoated
T25 flask and cultured at 37 °C in a 5% CO2 incubator.
The media in the flasks were refreshed every third day, and
at a 70% confluency state, the cells were trypsinized with
0.25% trypsin-EDTA for 5 min at 37 °C and subcultured.
Phase-contrast microscope images were taken at day 4 of
the primary culture.
2.2. Human skeletal muscle stem cell characterization by
flow cytometry
hSkMSCs were differentiated into two types of cells: skeletal
muscle cells and neuron-like cells. In order to characterize
the differentiation capacity of hSkMSCs, flow cytometry
was carried out. Immunophenotyping of hSkMSCs
was performed with antibodies against the following
cell surface antigens (BD Pharmingen, USA): CD44
(hyaluronate/lymphocyte homing associated cell adhesion
molecule: HCAM), CD34 (hematopoietic progenitor cell
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antigen), CD45 (protein tyrosine phosphatase, receptor
type, C/PTPRC/leukocyte common antigen/cell marker of
hematopoietic origin), CD90 (Thy-1/Thy-1.1), and CD105
(endoglin). Cells (1 × 104) were immunostained for each
antibody and analyzed by BD FACSCalibur flow cytometer
(BD Biosciences, USA). Samples were normalized to an
isotype control.
2.3. Myotube formation
The hSkMSCs were counted with a hemocytometer and the
cell concentration was calculated. The cells were plated on a
tissue culture dish approximately at 3 × 103 cells/cm2 using
DMEM/F12 medium supplemented with 20% FBS, 20 µg/L
EGF, and 10 µg/L bFGF. Following 24 h of incubation, the
FBS percentage was lowered to 10%. At the end of 7 and
14 days of incubation, the multinucleated myotubes were
observed under a light microscope. Immunocytochemical
staining was carried out using the streptavidin–peroxidase
method (UltraVision Plus Large Volume Detection System
Anti-Polyvalent, HRP Immunostaining Kit; Thermo
Scientific, UK) to reveal the desmin positive myotubes
obtained after 7 days of incubation. Briefly, cultured cells
were fixed in ice-cold methanol with 0.3% hydrogen
peroxide for 15 min and allowed to dry. After washing with
phosphate-buffered saline (PBS), the cells were incubated
with Ultra V Block for 5 min at room temperature and
then with the primary antibody for desmin (sc-14026;
Santa Cruz Biotechnology, USA) overnight at 4 °C. The
following day, biotinylated secondary antibody was added
and cells were incubated for 15 min at room temperature.
Streptavidin peroxidase treatment was then carried out
for 15 min at room temperature. The signal was detected
with the AEC kit (Zymed Laboratories/Invitrogen, USA).
After being counter-stained with hematoxylin (Santa
Cruz Biotechnology), cells were examined under a light
microscope.
2.4. Neuron-like cell differentiation
The hSkMSCs were counted with a hemocytometer and the
cells were plated on a tissue culture dish (approximately 1.5
× 103 cells/cm2) using DMEM/F12 medium supplemented
with 20% FBS, 20 µg/L EGF, and 10 µg/L bFGF. Cell
morphology was observed after 24 h of incubation to ensure
cell attachment to the surface. The cells were rinsed twice
with DPBS and complete neural differentiation medium
(AdvanceSTEM Neural Differentiation Medium and
AdvanceSTEM Stem Cell Growth Supplement (Thermo)
mixed in a 9:1 ratio according to the manufacturer’s
recommendation) was added. The cells were incubated
at 37 °C in a 5% CO2 incubator. Every 48 h, the neural
differentiation medium was refreshed. Neuronal
differentiation was observed as neuron-like cells appeared
within 24 h and peaked at 72 h of incubation. In order to
maintain cells in their differentiated state, additional neural
differentiation medium was added every 48 h.
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2.5. Neuron-like cell characterization by immunostaining
The cells were incubated in an incubator for 3 days in
complete neural differentiation media and finally fixed and
immunostained for beta-tubulin3 (Santa Cruz, sc-69966),
nestin (Santa Cruz, sc-21248), and GFAP (Santa Cruz,
sc-6171). Briefly, the cells on the slides were rinsed with
PBS and fixed in cold 3.7% formaldehyde for 10 min at RT.
After a subsequent wash in PBS, the slides were incubated
with 1.5% blocking serum of the species used to raise the
secondary antibodies (Santa Cruz Biotechnology) for 20
min at 37 °C to suppress the nonspecific binding of IgGs.
After washing three times with PBS for 5 min each, the
cells were incubated overnight at 4 °C with the primary
antibodies specific for the beta-tubulin3 and GFAP or
nestin. After washing 3 times, the slides were incubated
with secondary antimouse and antirabbit antibodies,
respectively, for 45 min in dark. Finally the samples were
counterstained with DAPI (Sigma-Aldrich) for 15 min,
washed three times again, mounted, and observed under a
confocal microscope (LSM; Zeiss, Germany).
2.6. Isolation of HUVECs
Collection of umbilical cords was done after full-term births
with informed consent of the mothers, who had a normal
delivery or cesarean section. They were aseptically stored
at 4 °C in HBSS with 2% Pen/Strep until processing. The
cords were washed extensively with PBS to remove the
blood clots. Culture medium was flushed through the vein
to blow out the coagulated blood. One end of the vein was
closed with a clamp and, after air removal, it was filled with
0.1% collagenase I (from Clostridium histolyticum, GIBCO)
prepared in HBSS, and the open end was closed with
another clamp to retain the enzyme solution in the vein.
The umbilical cord was placed into a 50-mL Falcon tube
containing warm PBS and incubated in a shaking water bath
at 37 °C for 25 min. One end of the vein was cut, the enzyme
solution containing the endothelial cells was taken into a 15mL Falcon tube, and the lumen of the vein was washed with
the medium to retrieve all detaching endothelial cells. After
centrifugation, the cell pellet was resuspended in endothelial
cell growth medium-2 (EGM-2; Lonza) completed with 2%
FBS and transferred into a gelatin-coated T25 flask. Human
umbilical vein endothelial cells (HUVECs) were cultured in
a 5% CO2 incubator at 37 °C until a 70% confluent monolayer
was reached. They were then trypsinized and cryopreserved.
The purity of HUVECs was determined by immunostaining
with the primary antibody specific to the endothelial
cell surface marker CD31 (Invitrogen) according to the
procedure mentioned in Section 2.5.
2.7. Coculture of hSkMSCs and HUVECs
HUVECs were cocultured with the hSkMSCs to test their
potential to form a capillary network, which is particularly
important in the development of tissue-engineered skeletal
muscle constructs.
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In order to optimize the hSkMSC and HUVEC
coculture, different media compositions were investigated.
Growth medium of hSkMSCs (DMEM/F12 medium
supplemented with 20% FBS) was tested at different
FBS concentrations either alone or in a 1:1 mixture
with the growth medium of HUVECs (EGM-2 medium
supplemented with 2% FBS). Six types of media were
tested in the coculture: 1) DMEM/F12 medium with 5%
FBS, 2) DMEM/F12 medium with 10% FBS, 3) DMEM/
F12 medium with 20% FBS, 4) DMEM/F12 medium with
5% FBS : EGM-2 medium with 2% FBS (1:1), 5) DMEM/
F12 medium with 10% FBS : EGM-2 medium with 2% FBS
(1:1), and 6) DMEM/F12 medium with 20% FBS : EGM-2
medium with 2% FBS (1:1) (Table).
hSkMSCs and HUVECs were mixed in a 1:1 ratio and
7 × 103cells/well were seeded on untreated coverslips in
24-well plates. The cells were incubated in an incubator
for 13 days in optimization media, then fixed and
immunostained. The same procedure as in Section 2.5
was carried out. This time the primary antibodies were
changed to myogenic marker desmin (Santa Cruz) and
endothelial marker CD31 (Invitrogen).
2.8. In vitro human skeletal muscle model: coculture of
myotubes, neuron-like cells, and the capillary network
To obtain the in vitro model of the human skeletal muscle,
the coculture of hSkMSCs and HUVECs was carried
out for 13 days. First, cells were mixed in a 1:1 ratio and
seeded (7 × 103 cells/well) on untreated coverslips in a

24-well plate. On day 14, the neuron-like cells obtained
by differentiating the hSkMSC in a separate culture were
trypsinized and added on top of the cocultured cells
with a density of 4 × 103 cells per well. The coculture
containing three different cell types was continued for 24
h in the neural differentiation medium (AdvanceSTEM
Neural Differentiation Medium and AdvanceSTEM Stem
Cell Growth Supplement (Thermo) mixed in a 9:1 ratio
according to the manufacturer’s recommendation) and
the cells were fixed and immunostained. The procedure
mentioned in Section 2.5 was carried out, but the primary
antibodies were changed to myogenic marker desmin,
endothelial marker CD31, and neuronal marker betatubulin3.
3. Results
3.1. Human skeletal muscle stem cell characterization
Isolated human skeletal muscle stem cells were examined
under a phase-contrast microscope and cell morphology
was evaluated. The preplate contained mostly cells of
fibroblastic morphology, while the flask generated from
cells floating in the medium of the preplate contained
mainly myoblasts that formed colonies (Figures 1A and
1B). In order to confirm the capability of myoblasts to
form multinucleated myotubes, they were incubated in
DMEM/F12 medium with the FBS amount reduced to
10% for 14 days and the myotubes were examined under
the phase-contrast microscope (Figure 2). Nuclei number

Table. Media types tested in the coculture of hSkMSCs and HUVECs, and their FBS contents. Media mixtures were prepared in 1:1
volumetric ratio.
Medium type/code

D5

D10

D20

D5-E2

D10-E2

D20-E2

DMEM/F12 (D)

5% FBS

10% FBS

20% FBS

5% FBS

10% FBS

20% FBS

EGM-2 (E)

-

-

-

2% FBS

2% FBS

2% FBS

Figure 1. Phase-contrast micrographs of human skeletal muscle derived cells after 4 days of incubation: A) cells on the preplate, B)
skeletal muscle myoblast colonies. Scale bars represent ~100 µm.
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of myotubes increased from day 7 to day 14 (Figures 2A
and 2B).
Flow cytometry results of isolated human skeletal
muscle stem cells revealed that they expressed the
characteristic surface markers of mesenchymal stem cells
— CD44 (95.30% positive), CD90 (96.83% positive), and
CD105 (85.58% positive) — and they were negative for
hematopoietic cell surface markers CD45 (1.27% positive)
and CD34 (0.78% positive) (Figure 3).

3.2. Neuron-like cell differentiation and characterization
Neuron-like cell differentiation was determined by
confocal microscopy after staining the cells for nestin
(an early neuronal marker), beta-tubulin3 (a neuronal
marker), and GFAP (an astrocyte marker). Neurons and
astrocytes can be distinguished with this staining; the cells
subjected to neuronal differentiation were found negative
for GFAP (Figure 4A), while they stained positive for betatubulin3 and nestin (Figure 4B). Nestin is an intermediate

Figure 2. Myotubes obtained by fusion of myoblasts in DMEM/F12 medium with 10% FBS: A) bright-field image of myotubes
immunohistochemically stained for desmin after 7 days of culture, B) phase-contrast micrograph of myotubes obtained after 14 days
of culture. Scale bars represent ~100 µm.

Figure 3. Flow cytometry histograms of human skeletal muscle stem cell surface antigens: CD44, CD90, CD45, CD34, CD105, and their
isotype control.
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Figure 4. Confocal micrographs of hSkMSCs subjected to neuronal differentiation and stained for A) beta-tubulin3: green, GFAP:
red, nuclei (DAPI): blue; B) beta-tubulin3: green, nestin: red, nuclei (DAPI): blue. Cells were negative for GFAP, which is an astrocyte
marker, and positive for nestin and beta-tubulin3.

filament protein and neural stem/progenitor cell marker. It
was shown to be required for the survival and self-renewal
of neural stem cells (Namiki et al., 2012). During neuroand gliogenesis, nestin is replaced by cell type-specific
intermediate filaments such as neurofilaments and GFAP
(Michalczyk and Ziman, 2005).
3.3.
Characterization
of
HUVECs
by
immunocytochemistry
Phase-contrast micrographs of HUVECs at day 4 of
primary culture were obtained and HUVECs at passage
2 were immunostained for endothelial cell surface
marker CD31 (Figure 5). HUVECs had the characteristic
cobblestone morphology and stained positive for CD31.
3.4. Coculture of hSkMSCs and HUVECs
HUVECs and hSkMSCs were incubated in an incubator
for 10 days, which is the minimum time required to obtain
a capillary network formation in optimized media. After
fixation, they were immunostained for the myogenic
marker desmin and the endothelial marker CD31.
In DMEM/F12 media supplemented with 5%, 10%,
and 20% FBS, the HUVECs did not survive (Figure 6).
Whenever EGM-2 medium was combined with DMEM/
F12, HUVECs survived and proliferated (Figures 7).
Although the capillary network formation was more
robust in the DMEM/F12 (5% FBS) : EGM-2 (2% FBS)
(1:1) mixture (Figures 7A and 7B), the myoblasts formed
aggregates just beneath the capillary network center
and no myotube formation could be detected. The best
multinucleated myotube and capillary network formation

in the coculture of hSkMSCs and HUVECs was obtained
in the DMEM/F12 (10% FBS) : EGM-2 (2% FBS) (1:1)
mixture (Figures 7C and 7D). On the other hand, when
the media mixture with the highest FBS concentration
was used (DMEM/F12 (20% FBS) : EGM-2 (2% FBS) (1:1)
mixture) (Figures 7E and 7F), the capillaries were found
to be more stunted and myotube formation could not take
place.
3.5. In vitro human skeletal muscle model: coculture of
myotubes, neuron-like cells, and the capillary network
In order to have the three cell types in the coculture in
their differentiated functional state, i.e. myotubes formed
by satellite cells, capillaries formed by endothelial cells,
and neuron-like cells from hSkMSCs, separate precultures
were performed before the final combination step.
Coculture of hSkMSCs and HUVECs for 13 days in the
DMEM/F12 (10% FBS) : EGM-2 (2% FBS) (1:1) mixture
resulted in formation of myotubes and a capillary network.
The neuron-like cells were obtained by differentiating the
hSkMSCs in a separate culture and were finally transferred
on top of the cocultured myotubes and capillaries.
Confocal micrographs showed that the neuron-like cells
were in association with the myotubes in the coculture of
three different cells incubated together for 24 h (Figure 8).
The Z-stack projection of myotubes and the capillary
network maintained in the three-cell coculture is depicted
in Figure 9, which reveals that myotubes were distributed
near the bottom and middle sections while the capillary
network resided on top of them.
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Figure 5. Human umbilical vein endothelial cells (HUVECs) in culture: A) phase-contrast micrograph of HUVECs after 4 days of
incubation, B) fluorescence micrograph of HUVECs (at passage 2) immunostained for their cell surface marker CD31 (green). Scale
bar in A represents ~100 µm.

Figure 6. Confocal micrographs of hSkMSC-HUVECs cocultured in DMEM/F12 medium supplemented with A) 5%, B) 10%, and C)
20% FBS. CD31: Green, desmin: red, nuclei (DAPI): blue.

4. Discussion
This study aimed to develop a novel human in vitro skeletal
muscle model by coculture of human neuron-like cells and
myotubes obtained from human skeletal muscle-derived
stem cells and a capillary network obtained from human
umbilical vein endothelial cells.
The muscle stem cells used in this study were isolated
by whole tissue digestion. The preplating method (QuPetersen et al., 2002) was adapted to leave the fast-adhering
fibroblasts in the preplate and the experiments were
performed with the enriched muscle stem cells. The muscle
stem cells, cultured in a medium of high FBS percentage
to prevent myoblast maturation, were characterized by
flow cytometry for their cell surface markers. Passage 2
cells were determined to be positive for the mesenchymal
stem cell markers CD44, CD90, and CD105 and negative
for the hematopoietic lineage markers CD34 and CD45.
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Chirieleison et al. (2012) used the preplate approach to
determine the phenotypic characteristics of the human
skeletal muscle stem cells that attached differentially to the
surface in a time-dependent manner. The skeletal muscle
cells used by this group adhered to the tissue culture
plate surface between the first 30 and 60 min (PP2) and
expressed the same surface markers as the cells used in our
study.
Human skeletal muscle contains not only the satellite
cells that mature in vitro into myoblasts and fuse with
each other to form the myotubes, but also a population
of multipotent stem cells that are able to differentiate into
osteoblasts, adipocytes, and neurons. Recently, Tamaki et
al. (2015) were able to show that CD34–/CD45–/CD29+
cells from human skeletal muscle actively contributed to
muscle fiber regeneration in vivo, while CD34+/CD45–
cells vigorously engrafted into the interstitium associated
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Figure 7. Confocal micrographs of hSkMSC-HUVEC cocultured in DMEM/F12 : EGM-2 (1:1) media supplemented
with different FBS concentrations. A, B) D5-E2; C, D) D10-E2; E, F) D20-E2. CD31: Green, desmin: red, cell nuclei
(DAPI): blue.
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Figure 8. Confocal micrographs of (A, B) neuron-like cells in association with myotubes in the human in vitro skeletal muscle model
formed by coculturing myotubes, capillary networks, and the neuron-like cells for 24 h. Beta-tubulin3: Green, desmin: red, cell nuclei
(DAPI): blue.

with differentiation into Schwann cells and perineural/
endoneural cells together with vascular endothelial cells
and pericytes. At least two groups reported differentiation
of human skeletal muscle-derived stem cells into neurons
in vitro: Alessandri et al. (2004) isolated the skeletal muscle
stem cells in a serum-free medium and showed their
capability to differentiate into both neurons and astrocytes.
Schultz and Lucas (2006) showed the potential of skeletal
muscle stem cells to differentiate more into neurons and
less into astrocytes when cultured in a neurococktail. A
commercially available neuronal differentiation medium
was used in our study and the resulting neuron-like cells
were found positive for neuronal markers nestin and betatubulin3 and negative for the astrocyte marker GFAP.
In recent years there has been an attempt to generate
vascularized muscle flaps through coculture of myoblasts
with HUVECs in order to get a better in vivo integration and
help the survival of the cells within the thick 3D transplant.
HUVECs require a growth factor cocktail to survive and
proliferate in vitro. It is known that FBS contains growth
factors and mesenchymal stem cells also secrete some
growth factors like VEGF that may help HUVEC survival.
In a study by Nagamori et al. (2013), HUVEC migration
was studied through the human skeletal muscle myoblast
sheets and the capillary network formation was observed
within the myoblast sheets. This was attributed to the local
feeding of cytokines like VEGF, FGF, and HGF from the
myoblasts. However, outside the sheets, HUVECs did not
grow in DMEM containing 10% FBS. On the contrary to
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our expectations, neither an increase in FBS concentration
in the DMEM/F12 medium nor the skeletal muscle
mesenchymal stem cell support could help HUVEC
survival and capillary network formation in the absence of
the endothelial cell growth medium. FBS concentration is
critical for myotube formation and should be considered in
a coculture; FBS promotes myoblast proliferation instead
of myoblast fusion when used at a concentration of 20%.
Therefore, neither myotubes nor a capillary network could
be obtained in the coculture of HUVECs with myoblasts at
that concentration in a DMEM/F12 medium.
A 1:1 volumetric combination of DMEM/F12 and
EGM-2 helped HUVEC survival and capillary network
formation in culture. A final concentration of 3.5% FBS (in
the D5:E2 medium), on the other hand, caused myoblast
aggregate formation. The best media combination for both
capillary network and myotube formation was found as
DMEM/F12:EGM-2 with a final FBS concentration of 6%.
Increase of FBS concentration to 11% did not cause any
improvement and was even found to be worse. When the
immortalized mouse myoblast cell line C2C12 was used
in such a coculture, fibroblasts were also needed to induce
a more physiological capillary network formation by the
HUVECs (Levenberg et al., 2005; Shandalov et al., 2014).
On the other hand, when primary human myoblasts
were used in coculture with HUVECs, capillary network
formation was obtained (Gholobova et al., 2015) without
a need for fibroblasts. This outcome can be attributed to
the presence of mesenchymal stem cells, or pericytes,
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Figure 9. Sequential confocal micrographs of a Z-stack of capillary network and myotubes in the human in vitro skeletal muscle model
formed by coculturing myotubes, capillary networks, and the neuron-like cells for 24 h. CD31: Green, desmin: red, cell nuclei (DAPI):
blue. Scale bar: 50 µm.

among the primary human skeletal muscle-derived cells.
Coculture of primary human myoblasts with HUVECs in
our study resulted in capillary network formation within
10 days, and as mentioned above it was dependent on the
percentage of FBS used in the culture.
To have a better human skeletal muscle model that
closely mimics the native tissue’s structure and function,
there is a need to incorporate motor neurons into the
vascularized structure, so that neuromuscular synapses are

formed. Neuron-like cells derived from primary human
skeletal muscle stem cells were seeded on the vascularized
myotubes in our study to obtain neuromuscular junctions
in the coculture. Selection and optimization of the
culture medium becomes a crucial challenge when
the coculture of three different cells is needed in vitro,
since every cell type has its own requirements of growth
factors and/or hormones. Since each cell type utilizes a
medium of different composition, when it comes time
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to coculture them all together in the same compartment
it is essential to determine how these different media or
their combinations affect cell morphology and culture
consistency. Considering our experience with HUVEC
and human skeletal muscle stem cell coculture and the
literature on human endothelial cell line and human neural
stem cell line coculture (Chou et al., 2014), it is possible to
say that a 50:50 mixture of two specific media supports the
cell morphology well in a two-cell coculture. Regarding
the coculture of motoneurons with functional myotubes,
Guo et al. (2011) showed that an in vitro functional
human neuromuscular junction can be established by
coculture of motoneurons derived from human fetal
spinal cord stem cells and myotubes derived from human
skeletal muscle stem cells in a defined serum-free system,
which consisted of sequential use of several different
media: coculture media rich in neurotrophic factors for
4 days followed by NBActiv 4 medium thereafter. At
the end of 24 h of culture of our human skeletal muscle
model in the commercial neuronal differentiation
medium, the neuron-like cells were found to be alive
and in association with the myotubes, and the capillary
network was also maintained. Our preliminary results
with neuron-like cell and myotube coculture suggest
that the neuronal differentiation medium cannot support
the intact morphology of myotubes in the coculture
beyond 48 h, and it also does not support endothelial cell
survival. As was done in the study by Guo et al. (2011),
our three-cell coculture may need a replacement or
combination of neuronal differentiation medium with a
medium like NBActiv 4 after 24 h of initiation culture.
NBActiv 4 medium did not harm endothelial cells in their
monoculture carried out for 4 days, but if the capillary
network in the three-cell coculture is affected, addition of
EGM-2 to the coculture may be considered, too.

To our knowledge, our group has reported for the first
time a human skeletal muscle model containing advanced
capillary networks, neurons, and myotubes in association
with each other, by coculturing HUVECs, myoblasts,
and human muscle stem cell-derived neuron-like cells.
Takahashi et al. (2015) reported in their very recent study
that a capillary network and human induced pluripotent
stem cell-derived neurons were associated with human
myoblast sheets when sandwiched in between, but
myotube and neuromuscular junction formation between
the neurons and myotubes was not indicated in this
engineered muscle tissue.
In conclusion, in this study, a complex in vitro human
skeletal muscle model containing capillary networks and
interacting myotubes and neuron-like cells was developed.
This skeletal muscle model was characterized by confocal
microscopy. The best multinucleated myotube and
capillary network formation in the coculture of hSkMSCs
and HUVECs was obtained in the DMEM/F12 (10% FBS)
: EGM-2 (2% FBS) (1:1 v/v) mixture. Coculture of the
myotubes, capillary network, and neuron-like cells was
successful for 24 h in the neural differentiation medium.
Further detailed analyses such as the determination of the
presence and functionality of the neuromuscular junctions
in this model and extension of coculture time beyond 24
h are in progress. Our model has the potential to be used
in the design of in vitro accurate physiological models of
skeletal muscle tissue for various applications like drug
testing and toxicology studies. We obtained the composite
of muscle fibers, nerves, and capillaries in vitro that
would serve as the best muscle tissue substitute for both
functional treatment and coverage of a skeletal muscle
defect. This model will be useful in ensuring functional
muscle regeneration and may eliminate the need for any
kind of muscle transfer in future.
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